NeurologyOnline.net

Neurology Xagena

A study by Indiana University researchers has identified 24 compounds, including Caffeine, with the potential to boost an enzyme in the brain shown to protect against dementia. The protective effec ...


The objective of a study was to determine whether oral anticoagulation treatment ( OAT ) resumption after primary intracerebral hemorrhage ( ICH ) is associated with long-term outcome. Oral anticoa ...


Drugs used to treat diabetes could also be used to treat Alzheimer's disease, according to new research from the University of Aberdeen. This is also the first study of its kind to show that Alzheime ...


According to Iowa State University researchers, higher levels of the enzyme, autotaxin, significantly predict memory impairment and type 2 diabetes. Autotaxin, often studied in cancer research, is ...


Higher Caffeine consumption has been associated with reduced risk of Parkinson's disease, and with a more benign progression of motor and non-motor symptoms. An observational cohort study investigat ...


Orthostatic hypotension is increasingly reported as a risk factor for development of late-stage disease features in Parkinson disease. Less is known about its significance in individuals with early Pa ...


Creatine is an antioxidant agent that has shown neuroprotective effects in animal models of Parkinson's disease. Creatine was selected by the National Institute of Neurological Disorders and Stroke ( ...


The first transplantation of stem cells in patients with Parkinson's disease is almost within reach. However, it remains a challenge for researchers to control stem cells accurately in the lab in orde ...


Many patients with Parkinson's disease develop mild cognitive impairment ( MCI ) or dementia. Identifying biomarkers for cognitive impairment could be instrumental in facilitating both early diagnosis ...


Prostate cancer growth and progression may be linked to neurogenesis and to medical anti- Parkinson treatment, but results are inconclusive. Therefore, researchers have examined the association betwee ...


Multiple sclerosis is an autoimmune inflammatory neurological disease with complex aetiology where the causes are not completely known. The main aim of this thesis was to investigate the influence o ...


Immunogenicity of biopharmaceutical products in multiple sclerosis is a frequent side effect which has a multifactorial etiology. Researchers have assessed associations between anti-drug antibody ...


New disease-modifying treatment strategies in multiple sclerosis offer possibilities for individualised treatment. In a study, researchers evaluated patient-reported outcome measures before and afte ...


Verubecestat is an investigational small molecule inhibitor of the enzyme beta-site amyloid precursor protein cleaving enzyme 1 ( BACE1 ) for the potential treatment of Alzheimer’s disease. A resear ...


New efficacy data for investigational Cladribine tablets were presented at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis ( ECTRIMS ), in London. The fi ...